Literature DB >> 12388840

Residual oil fly ash increases the susceptibility to infection and severely damages the lungs after pulmonary challenge with a bacterial pathogen.

James M Antonini1, Jenny R Roberts, Michael R Jernigan, Hui-Min Yang, Jane Y C Ma, Robert W Clarke.   

Abstract

Inhalation of residual oil fly ash (ROFA), a component of ambient particulate matter, has been shown to increase pulmonary morbidity and impair lung defense mechanisms in exposed workers. Our objective was to evaluate the effect of ROFA preexposure on lung defense and injury after pulmonary challenge with a bacterial pathogen. Male Sprague-Dawley rats were dosed intratracheally at day 0 with saline (control) or ROFA (0.2 or 1 mg/100 g body weight). Three days later, a low (5 x 10(3)) or high (5 x 10(5)) dose of Listeria monocytogenes was instilled intratracheally into the ROFA- and saline-treated rats. Bronchoalveolar lavage was performed on the right lungs at days 6, 8, and 10. The recovered cells were differentiated, and chemiluminescence (CL) and nitric oxide (NO) production, two indices of alveolar macrophage (AM) function, were measured. At the same time points, the left lung and spleen were removed, homogenized, and cultured, and colony-forming units were counted after an overnight incubation. Exposure to ROFA and the high dose of L. monocytogenes led to marked lung injury and inflammation as well as to an increase in mortality, compared with rats treated with saline and the high dose of L. monocytogenes. Preexposure to ROFA significantly enhanced injury and delayed the pulmonary clearance of L. monocytogenes at both bacterial doses when compared to the saline-treated control rats. ROFA had no effect on AM CL but caused a significant suppression of AM NO production, as compared to the saline control rats. We have demonstrated that acute exposure to ROFA slowed the pulmonary clearance of L. monocytogenes. The suppression in AM NO production by ROFA pretreatment likely plays an important role. These results suggest that pulmonary exposure to ROFA may alter AM function and lead to increased susceptibility to lung infection in exposed populations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12388840     DOI: 10.1093/toxsci/70.1.110

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  15 in total

1.  Effect of concentrated ambient particles on macrophage phagocytosis and killing of Streptococcus pneumoniae.

Authors:  Hongwei Zhou; Lester Kobzik
Journal:  Am J Respir Cell Mol Biol       Date:  2006-11-01       Impact factor: 6.914

2.  Dysregulation of macrophage activation profiles by engineered nanoparticles.

Authors:  Vamsi Kodali; Matthew H Littke; Susan C Tilton; Justin G Teeguarden; Liang Shi; Charles W Frevert; Wei Wang; Joel G Pounds; Brian D Thrall
Journal:  ACS Nano       Date:  2013-07-09       Impact factor: 15.881

3.  Inhibition of beta-defensin gene expression in airway epithelial cells by low doses of residual oil fly ash is mediated by vanadium.

Authors:  Marcia E Klein-Patel; Gill Diamond; Michele Boniotto; Sherif Saad; Lisa K Ryan
Journal:  Toxicol Sci       Date:  2006-04-26       Impact factor: 4.849

4.  In vitro and in vivo assessment of pulmonary risk associated with exposure to combustion generated fine particles.

Authors:  Baher Fahmy; Liren Ding; Dahui You; Slawo Lomnicki; Barry Dellinger; Stephania A Cormier
Journal:  Environ Toxicol Pharmacol       Date:  2010-03       Impact factor: 4.860

5.  Metal composition and solubility determine lung toxicity induced by residual oil fly ash collected from different sites within a power plant.

Authors:  James M Antonini; Michael D Taylor; Stephen S Leonard; Nicholas J Lawryk; Xianglin Shi; Robert W Clarke; Jenny R Roberts
Journal:  Mol Cell Biochem       Date:  2004-01       Impact factor: 3.396

6.  California wildfires of 2008: coarse and fine particulate matter toxicity.

Authors:  Teresa C Wegesser; Kent E Pinkerton; Jerold A Last
Journal:  Environ Health Perspect       Date:  2009-02-02       Impact factor: 9.031

7.  Sequential exposure to carbon nanotubes and bacteria enhances pulmonary inflammation and infectivity.

Authors:  Anna A Shvedova; James P Fabisiak; Elena R Kisin; Ashley R Murray; Jenny R Roberts; Yulia Y Tyurina; James M Antonini; Wei Hong Feng; Choudari Kommineni; Jeffrey Reynolds; Aaron Barchowsky; Vince Castranova; Valerian E Kagan
Journal:  Am J Respir Cell Mol Biol       Date:  2007-12-20       Impact factor: 6.914

8.  Systemic microvascular dysfunction and inflammation after pulmonary particulate matter exposure.

Authors:  Timothy R Nurkiewicz; Dale W Porter; Mark Barger; Lyndell Millecchia; K Murali K Rao; Paul J Marvar; Ann F Hubbs; Vincent Castranova; Matthew A Boegehold
Journal:  Environ Health Perspect       Date:  2006-03       Impact factor: 9.031

Review 9.  Nanoparticles: health effects--pros and cons.

Authors:  Maureen R Gwinn; Val Vallyathan
Journal:  Environ Health Perspect       Date:  2006-12       Impact factor: 9.031

10.  Origin and health impacts of emissions of toxic by-products and fine particles from combustion and thermal treatment of hazardous wastes and materials.

Authors:  Stephania A Cormier; Slawo Lomnicki; Wayne Backes; Barry Dellinger
Journal:  Environ Health Perspect       Date:  2006-06       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.